Caffeine as a Therapeutic Agent in Parkinson's disease
Caffeine as a Therapeutic Agent in Parkinson's disease
批准号:
266514
负责人:
Postuma Ronald B
金额:
$42.67万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2018-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease is a common neurodegenerative disorder in which patients experience progressive motor disability and many disabling non-motor symptoms. Recent studies have consistently found that people who do not use caffeine are at higher risk of de
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroimaging Prodromal Neurodegeneration in Synucleinopathy
-
批准号:380556
-
项目类别:Operating Grants
-
资助金额:$67.16万
-
财政年份:2018
-
负责人:Postuma Ronald B
-
依托单位:
Caffeine for Somnolence and Motor Manifestations of Parkinson's disease
-
批准号:199116
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2010
-
负责人:Postuma Ronald B
-
依托单位:
Improving Detection and Management of Non-motor Features of Parkinson's disease - Development of a Knowledge Translation Outreach Strategy
-
批准号:187217
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Postuma Ronald B
-
依托单位:
海外基金